Prenatal diagnosis and outcome of fetal bradyarrhythmias;Pränatale differentialdiagnostik und verlauf fetaler bradyarrhythmien

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 208, Issue 2, 2004, Pages 57-62

  Tollens, M ^a   Schneider, K T M ^a   Lang, D ^a,b   Oberhoffer, R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Autoantibodies; Congenital atrioventricular block; Fetal doppler echocardiography

Indexed keywords

CORTICOSTEROID; LA ANTIBODY; MATERNAL ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; COLLAGEN DISEASE; COMORBIDITY; COMPLETE HEART BLOCK; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS ELECTROCARDIOGRAPHY; GESTATIONAL AGE; HUMAN; MATERNAL TREATMENT; OUTCOMES RESEARCH; PRENATAL DIAGNOSIS; PROGNOSIS; RETROSPECTIVE STUDY;

BRADYCARDIA; COLLAGEN DISEASES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FETAL DISEASES; HEART BLOCK; HEART DEFECTS, CONGENITAL; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROGNOSIS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

EID: 2442461066     PISSN: 09482393     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818959     Document Type: Article

References (30)

1. Allan LD. Research protocol for fetuses with complete heart block. Ultrasound Obstet Gynecol 1995; 5: 349-352
2. Allan LD, Anderson RH, Sullivan ID, Campbell S, Holt DW, Tynan M. Evaluation of fetal arrhythmias by echocardiography. Br-Heart-J 1983; 50: 240-5
3. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block. Lupus 1995; 4(2); 116-21
4. Frohn-Mulder IM, Meilof JF, Szatmari A, Stewart PA, Swaak TJ, Hess J. Clinical significance of maternal anti-Ro/SS-A antibodies in children with isolated heart block. J-Am-Coll-Cardiol 1994; 23(7): 1677-81
5. Meilof JF, Frohn-Mulder M, Stewart PA, Szatmari A, Hess J, Veldhoven CH, Smeenk RJ, Swaak AJ. Maternal autoantibodies and congenital heart block: no evidence for the existence of a unique heart block-associated anti-Ro/SS-A autoantibody profile. Lupus 1993; 2(4): 239-46
6. Buyon JP, Swersky SH, Fox HE, Bierman FZ, Winchester RJ. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus etythematosus. Experience in a mother with a predominance of SS-B (La) antibodies. Arthritis-Rheum 1987; 30(1): 44-9
7. Rosenthal E. Fetal heart block. In: Allen L, Hornberger L, Sharland BSc, eds. Textbook of Fetal Cardiolgy London: GMM, 2000: 438-451
8. Southall DP, Richards J, Hardwick RA, Shinebourne EA, Gibbens GL, Thelwall-Jones H, de-Swiet M, Johnston PG. Prospective study of fetal heart rate and rhythm patterns. Arch-Dis-Child 1980; 55(7): 506-11
9. Silverman NH, Enderlein MA, Stanger P, Teitel DF, Heymann MA, Golbus MS. Recognition of fetal arrhythmias by echocardiography. J-Clin-Ultrasound 1985; 13(4): 255-63
10. Calvin SE, Gaziano EP, Bendel RP, Knox GE, Brandt DG. Evaluation of fetal cardiac arrhythmias. Ultrasound findings and neonatal outcome. Minn-Med 1992; 75(12): 29-31
11. Askanase AD, Friedmann DM, Copel J, Dische MR, Dubin A, Starc TJ, Katholi MC, Buyon JP. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSA/La antibodies. Lupus 2002; 11: 145-151
12. Ross BA. Congenital complete atrioventricular block. Pediatr-ClinNorth-Am 1990; 37(1): 69-78
13. Brucato A, Jonzon A, Friedman D, Allan LD, Vignati G, Gasparini M, Stein JI, Montella S, Michaelsson M, Buyon J. Proposol fora new definition of congenital complete atrioventricular block. Lupus 2003; 12: 427-435
14. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996; 75(2): 190-4
15. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J-Am-Coll-Cardiol 1991; 17(6): 1360-6
16. Ramsey-Goldmann R, Hom D, Deng JS et al. Anti-SSA antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis & Rheumatism 1986; 29: 1269-1273
17. Brucato A. Risk of congenitalcomplete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmuno-electrophoresis. Arthritis & Rheumatism 2001; 44: 1832-1835
18. Cimaz R, Spence DL, Hornberger L, Silverman ED. Incidence and spectrum of neonatal lupus erythematosus. A prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 2003; 142: 678-683
19. Friedmann DM, Rupel A, Glickstein J, Buyon JP. Congenital heart block in neonatal lupus: the pediatric cardiologists perspective. Indian J Pediatr 2002; 69(6): 517-22
20. Buyon JP, Hiebert R, Copel J, Craft J, Friedmann D, Katholi M, Lee L, Provost P, Reichlin M, Rider L, Rupel A, Saleeb S, Weston W, Skovron ML. Autoimmune associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. JACC 1998; 31(7): 1658-1666
21. Friedman RA. Congenital AV block. Pace me now or pace me later? [editorial; comment] Circulation 1995; 92(3): 283-5
22. Wells M, Fox H. Immunology and Immunopathology of the maternofetal interface. In: Coulam CB, Faulk WP, McIntyre JA, eds. Immunological Obstetrics New York: WW Norton & Co, 1992: 166-172
23. Dörner T, Feist E, Pruss A, Chaoui R, Göldner B, Hiepe F. Significance of autoantibodies in neonatal lupus erythematosus. Int Arch Allergy Immunol 2000; 123: 58-66
24. Siren MK, Julkunen H, Kaaja R, Koskimies S. Congenital heart block; HLA differences between affected children and healthy siblings in four Finnish families. APMIS 1997; 105(6): 463-8
25. Smeenk RJ. Immunological aspects of congenital atrioventricular block. Pacing-Clin-Electrophysiol 1997; 20(8 Pt 2): 2093-7
26. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block. Arthritis & Rheumatism 1999; 42(11): 2335-2345
27. Wimmer AG, Oberhoffer R, Schneider KTM, Fleck M, Schölmerich J, Müller-Ladner U. Interdisziplinäre Betreuung von schwangeren Patienten mit Kollagenose (zur Publikation eingereicht).
28. Julkunen H, Kaaja R, Siren M, Mack C, McCready S, Holthöfer H, Kurki P, Maddison P. Immune Mediated Congenital Herat Block (CHB): Identifying and counseling Patients at risk for having children with CHB. Semin Arthritis Rheum 1998; 28: 97-106
29. Eronen M, Sirèn M, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and Long-Term Outcome of Children With Congenital Complete Heart Block Diagnosed In Utero or as a Newborn. Pediatrics 2000; 106: 86-91
30. Jaeggi ET, Hamilton RM, Silvermann ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. J Am Coll Cardiol 2002; 39: 130-7